
William A. Craigo
Examiner (ID: 17649, Phone: (571)270-1347 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 936 |
| Issued Applications | 383 |
| Pending Applications | 126 |
| Abandoned Applications | 445 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16310680
[patent_doc_number] => 20200289418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => METHOD FOR INCREASING BIOAVAILABILITY OF NATURAL BIOACTIVE MOLECULES USING BIO-POLYMER COMPLEXATION TECHNOLOGY
[patent_app_type] => utility
[patent_app_number] => 16/817438
[patent_app_country] => US
[patent_app_date] => 2020-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16817438
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/817438 | METHOD FOR INCREASING BIOAVAILABILITY OF NATURAL BIOACTIVE MOLECULES USING BIO-POLYMER COMPLEXATION TECHNOLOGY | Mar 11, 2020 | Abandoned |
Array
(
[id] => 17625580
[patent_doc_number] => 20220160595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => AN ANTIPERSPIRANT COMPOSITION COMPRISING REACTIVE SALTS
[patent_app_type] => utility
[patent_app_number] => 17/432999
[patent_app_country] => US
[patent_app_date] => 2020-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17432999
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/432999 | AN ANTIPERSPIRANT COMPOSITION COMPRISING REACTIVE SALTS | Mar 11, 2020 | Abandoned |
Array
(
[id] => 17843666
[patent_doc_number] => 11433006
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-06
[patent_title] => Methods, compositions, and delivery systems for therapeutic skin treatments
[patent_app_type] => utility
[patent_app_number] => 16/800015
[patent_app_country] => US
[patent_app_date] => 2020-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5963
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16800015
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/800015 | Methods, compositions, and delivery systems for therapeutic skin treatments | Feb 24, 2020 | Issued |
Array
(
[id] => 20301265
[patent_doc_number] => 12447235
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-21
[patent_title] => Hydrogel hybrid material, method of its preparation and application
[patent_app_type] => utility
[patent_app_number] => 17/426629
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 0
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17426629
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/426629 | Hydrogel hybrid material, method of its preparation and application | Feb 20, 2020 | Issued |
Array
(
[id] => 15960417
[patent_doc_number] => 20200163960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => INJECTABLE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 16/775222
[patent_app_country] => US
[patent_app_date] => 2020-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16775222
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/775222 | INJECTABLE FORMULATION | Jan 27, 2020 | Abandoned |
Array
(
[id] => 17503438
[patent_doc_number] => 20220096540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF LYSOSOMAL STORAGE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/310400
[patent_app_country] => US
[patent_app_date] => 2020-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310400
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/310400 | Pharmaceutical composition for prevention or treatment of lysosomal storage disorders | Jan 22, 2020 | Issued |
Array
(
[id] => 16204924
[patent_doc_number] => 20200237914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => Throat Lozenge
[patent_app_type] => utility
[patent_app_number] => 16/748758
[patent_app_country] => US
[patent_app_date] => 2020-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16748758
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/748758 | Throat Lozenge | Jan 20, 2020 | Abandoned |
Array
(
[id] => 17480466
[patent_doc_number] => 20220087970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => PREVENTION OF ANESTHETIC-INDUCED NEUROCOGNITIVE DYSFUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/421497
[patent_app_country] => US
[patent_app_date] => 2020-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26416
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17421497
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/421497 | PREVENTION OF ANESTHETIC-INDUCED NEUROCOGNITIVE DYSFUNCTION | Jan 17, 2020 | Abandoned |
Array
(
[id] => 17472352
[patent_doc_number] => 20220079856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => SUNSCREEN COSMETIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/423080
[patent_app_country] => US
[patent_app_date] => 2020-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8530
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423080
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/423080 | SUNSCREEN COSMETIC COMPOSITION | Jan 7, 2020 | Abandoned |
Array
(
[id] => 20127839
[patent_doc_number] => 12370139
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-29
[patent_title] => Use of edaravone in oral treatment of oxidative-stress mediated neurodegenerative disorders
[patent_app_type] => utility
[patent_app_number] => 16/733958
[patent_app_country] => US
[patent_app_date] => 2020-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 423
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16733958
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/733958 | Use of edaravone in oral treatment of oxidative-stress mediated neurodegenerative disorders | Jan 2, 2020 | Issued |
Array
(
[id] => 17618881
[patent_doc_number] => 11337906
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-24
[patent_title] => Hair care and conditioning compositions
[patent_app_type] => utility
[patent_app_number] => 16/731654
[patent_app_country] => US
[patent_app_date] => 2019-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17412
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16731654
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/731654 | Hair care and conditioning compositions | Dec 30, 2019 | Issued |
Array
(
[id] => 17355199
[patent_doc_number] => 20220015995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => AEROSOL FOAM DEVICE CONTAINING A COMPOSITION RICH IN FATTY SUBSTANCES
[patent_app_type] => utility
[patent_app_number] => 17/311288
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17311288
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/311288 | AEROSOL FOAM DEVICE CONTAINING A COMPOSITION RICH IN FATTY SUBSTANCES | Dec 18, 2019 | Abandoned |
Array
(
[id] => 16663921
[patent_doc_number] => 10933143
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-02
[patent_title] => Modified release formulations containing drug-ion exchange resin complexes
[patent_app_type] => utility
[patent_app_number] => 16/719121
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19051
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16719121
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/719121 | Modified release formulations containing drug-ion exchange resin complexes | Dec 17, 2019 | Issued |
Array
(
[id] => 17480533
[patent_doc_number] => 20220088037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => A SUSTAINED RELEASE COMPOSITION COMPRISING A HYDROXYALKYL METHYLCELLULOSE
[patent_app_type] => utility
[patent_app_number] => 17/312417
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312417
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/312417 | A SUSTAINED RELEASE COMPOSITION COMPRISING A HYDROXYALKYL METHYLCELLULOSE | Dec 16, 2019 | Abandoned |
Array
(
[id] => 16428218
[patent_doc_number] => 10828278
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-10
[patent_title] => Tesofensine and beta blocker combination formulations
[patent_app_type] => utility
[patent_app_number] => 16/705370
[patent_app_country] => US
[patent_app_date] => 2019-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 13250
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16705370
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/705370 | Tesofensine and beta blocker combination formulations | Dec 5, 2019 | Issued |
Array
(
[id] => 16204680
[patent_doc_number] => 20200237670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => DYE-STABILIZED NANOPARTICLES AND METHODS OF THEIR MANUFACTURE AND THERAPEUTIC USE
[patent_app_type] => utility
[patent_app_number] => 16/698572
[patent_app_country] => US
[patent_app_date] => 2019-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18255
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16698572
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/698572 | DYE-STABILIZED NANOPARTICLES AND METHODS OF THEIR MANUFACTURE AND THERAPEUTIC USE | Nov 26, 2019 | Abandoned |
Array
(
[id] => 16853549
[patent_doc_number] => 20210154294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => ELIMINATION OF EXOTIC PATHOGENS
[patent_app_type] => utility
[patent_app_number] => 16/698189
[patent_app_country] => US
[patent_app_date] => 2019-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12310
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16698189
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/698189 | ELIMINATION OF EXOTIC PATHOGENS | Nov 26, 2019 | Abandoned |
Array
(
[id] => 16491097
[patent_doc_number] => 10857115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug
[patent_app_type] => utility
[patent_app_number] => 16/696583
[patent_app_country] => US
[patent_app_date] => 2019-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5928
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16696583
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/696583 | Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug | Nov 25, 2019 | Issued |
Array
(
[id] => 17103101
[patent_doc_number] => 11123289
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-21
[patent_title] => Rapamycin for the treatment of lymphangioleiomyomatosis
[patent_app_type] => utility
[patent_app_number] => 16/695895
[patent_app_country] => US
[patent_app_date] => 2019-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21863
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16695895
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/695895 | Rapamycin for the treatment of lymphangioleiomyomatosis | Nov 25, 2019 | Issued |
Array
(
[id] => 17249872
[patent_doc_number] => 11185336
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-30
[patent_title] => Embolization device constructed from expansile polymer
[patent_app_type] => utility
[patent_app_number] => 16/678978
[patent_app_country] => US
[patent_app_date] => 2019-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9183
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16678978
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/678978 | Embolization device constructed from expansile polymer | Nov 7, 2019 | Issued |